BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28607106)

  • 1. UBASH3A Mediates Risk for Type 1 Diabetes Through Inhibition of T-Cell Receptor-Induced NF-κB Signaling.
    Ge Y; Paisie TK; Newman JRB; McIntyre LM; Concannon P
    Diabetes; 2017 Jul; 66(7):2033-2043. PubMed ID: 28607106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular-genetic characterization of common, noncoding UBASH3A variants associated with type 1 diabetes.
    Ge Y; Concannon P
    Eur J Hum Genet; 2018 Jul; 26(7):1060-1064. PubMed ID: 29491471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. USP18 negatively regulates NF-κB signaling by targeting TAK1 and NEMO for deubiquitination through distinct mechanisms.
    Yang Z; Xian H; Hu J; Tian S; Qin Y; Wang RF; Cui J
    Sci Rep; 2015 Aug; 5():12738. PubMed ID: 26240016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UBASH3A Interacts with PTPN22 to Regulate
    Newman JRB; Concannon P; Ge Y
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell receptor signals to NF-κB are transmitted by a cytosolic p62-Bcl10-Malt1-IKK signalosome.
    Paul S; Traver MK; Kashyap AK; Washington MA; Latoche JR; Schaefer BC
    Sci Signal; 2014 May; 7(325):ra45. PubMed ID: 24825920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protein phosphatase 2A regulatory subunit B56γ mediates suppression of T cell receptor (TCR)-induced nuclear factor-κB (NF-κB) activity.
    Breuer R; Becker MS; Brechmann M; Mock T; Arnold R; Krammer PH
    J Biol Chem; 2014 May; 289(21):14996-5004. PubMed ID: 24719332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UBASH3A Regulates the Synthesis and Dynamics of TCR-CD3 Complexes.
    Ge Y; Paisie TK; Chen S; Concannon P
    J Immunol; 2019 Dec; 203(11):2827-2836. PubMed ID: 31659016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TCR and CD28 activate the transcription factor NF-κB in T-cells via distinct adaptor signaling complexes.
    Thaker YR; Schneider H; Rudd CE
    Immunol Lett; 2015 Jan; 163(1):113-9. PubMed ID: 25455592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UBASH3A deficiency accelerates type 1 diabetes development and enhances salivary gland inflammation in NOD mice.
    Chen YG; Ciecko AE; Khaja S; Grzybowski M; Geurts AM; Lieberman SM
    Sci Rep; 2020 Jul; 10(1):12019. PubMed ID: 32694640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation and ubiquitination of the IkappaB kinase complex by two distinct signaling pathways.
    Shambharkar PB; Blonska M; Pappu BP; Li H; You Y; Sakurai H; Darnay BG; Hara H; Penninger J; Lin X
    EMBO J; 2007 Apr; 26(7):1794-805. PubMed ID: 17363905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains.
    Düwel M; Welteke V; Oeckinghaus A; Baens M; Kloo B; Ferch U; Darnay BG; Ruland J; Marynen P; Krappmann D
    J Immunol; 2009 Jun; 182(12):7718-28. PubMed ID: 19494296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive association of TGF-beta-activated kinase 1 with the IkappaB kinase complex in the nucleus and cytoplasm of human neutrophils and its impact on downstream processes.
    Ear T; Fortin CF; Simard FA; McDonald PP
    J Immunol; 2010 Apr; 184(7):3897-906. PubMed ID: 20200282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of protein kinase C theta, Bcl10, or Malt1 selectively impairs proliferation and NF-kappa B activation in the CD4+ T cell subset.
    Kingeter LM; Schaefer BC
    J Immunol; 2008 Nov; 181(9):6244-54. PubMed ID: 18941215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDK1 nucleates T cell receptor-induced signaling complex for NF-kappaB activation.
    Lee KY; D'Acquisto F; Hayden MS; Shim JH; Ghosh S
    Science; 2005 Apr; 308(5718):114-8. PubMed ID: 15802604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scaffold protein JLP mediates TCR-initiated CD4
    Yan Q; Yang C; Fu Q; Chen Z; Liu S; Fu D; Rahman RN; Nakazato R; Yoshioka K; Kung SKP; Ding G; Wang H
    Mol Immunol; 2017 Jul; 87():258-266. PubMed ID: 28521278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CaMKII targets Bcl10 in T-cell receptor induced activation of NF-κB.
    Oruganti SR; Edin S; Grundström C; Grundström T
    Mol Immunol; 2011 Jul; 48(12-13):1448-60. PubMed ID: 21513986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO.
    Zhou H; Wertz I; O'Rourke K; Ultsch M; Seshagiri S; Eby M; Xiao W; Dixit VM
    Nature; 2004 Jan; 427(6970):167-71. PubMed ID: 14695475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD28 stimulation triggers NF-kappaB activation through the CARMA1-PKCtheta-Grb2/Gads axis.
    Takeda K; Harada Y; Watanabe R; Inutake Y; Ogawa S; Onuki K; Kagaya S; Tanabe K; Kishimoto H; Abe R
    Int Immunol; 2008 Dec; 20(12):1507-15. PubMed ID: 18829987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCL11B enhances TCR/CD28-triggered NF-kappaB activation through up-regulation of Cot kinase gene expression in T-lymphocytes.
    Cismasiu VB; Duque J; Paskaleva E; Califano D; Ghanta S; Young HA; Avram D
    Biochem J; 2009 Jan; 417(2):457-66. PubMed ID: 18831712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative regulation of TCR signaling by NF-kappaB2/p100.
    Legarda-Addison D; Ting AT
    J Immunol; 2007 Jun; 178(12):7767-78. PubMed ID: 17548614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.